Search filters

List of works by Minne Casteels

Adult Refsum disease: a form of tapetoretinal dystrophy accessible to therapy

scientific article published on 20 September 2010

Alpha‐oxidation of 3‐methyl‐substituted fatty acids and its thiamine dependence

scientific article published on April 1, 2003

Are products with an orphan designation for oncology indications different from products for other rare indications? A retrospective analysis of European orphan designations granted between 2002-2012

scientific article published on 16 February 2017

Breakdown of 2-hydroxylated straight chain fatty acids via peroxisomal 2-hydroxyphytanoyl-CoA lyase: a revised pathway for the alpha-oxidation of straight chain fatty acids

scientific article

Call for a dedicated European legal framework for bacteriophage therapy.

scientific article published on 06 February 2014

Causes of drug shortages in the legal pharmaceutical framework

scientific article published on 12 January 2015

Clinical, Economic and Policy Implications of Drug Shortages in the European Union.

scientific article published on August 2016

Development and implementation of "Check of Medication Appropriateness" (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance

scientific article published on 11 February 2019

Drug shortages in European countries: a trade-off between market attractiveness and cost containment?

scientific article

Evaluation of drotrecogin alpha use in a Belgian university hospital

scientific article published on 01 October 2006

Financial based agreements and performance based agreements: the Belgian experience.

scientific article published on 5 October 2015

Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?

scientific article published on 16 August 2003

High-risk medication in community care: a scoping review

scientific article published on 05 February 2020

Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs

scientific article

Insights into European drug shortages: a survey of hospital pharmacists

scientific article

It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North-South collaborative trials

scientific article

Managed Entry Agreements for Oncology Drugs: Lessons from the European Experience to Inform the Future

scientific article

Market access of cancer drugs in European countries: improving resource allocation

scientific article

Meropenem -valproic acid interaction in patients with cefepime-associated status epilepticus.

scientific article published on January 2007

Optimizing the European regulatory framework for sustainable bacteriophage therapy in human medicine

scientific article published on 17 April 2012

Osteoporosis after combined use of a neuroleptic and antidepressants

scientific article published on 24 June 2008

Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy.

scientific article published on 18 October 2013

Predictors for reimbursement of oncology drugs in Belgium between 2002 and 2013.

scientific article published on 15 May 2015

Presence of thiamine pyrophosphate in mammalian peroxisomes

scientific article

Role of thiamine pyrophosphate in oligomerisation, functioning and import of peroxisomal 2-hydroxyacyl-CoA lyase

scientific article

Sharing of Clinical Trial Data and Samples: The Cancer Patient Perspective

scientific article published on 11 February 2020

Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines

scientific article published on 30 December 2015

Tamoxifen metabolism and efficacy in breast cancer- a prospective multicentre trial

scientific article published on 19 February 2018

The necessity for a European definition of drug shortages

scientific article published on 01 August 2018

Thiamine pyrophosphate: an essential cofactor in the mammalian metabolism of 3-methyl-branched fatty acids--implications for thiamine deficiencies?

scientific article

Time Investment in Drug Supply Problems by Flemish Community Pharmacies

scientific article published on 23 August 2017

Time spent by Belgian hospital pharmacists on supply disruptions and drug shortages: An exploratory study

scientific article

Toward a European definition for a drug shortage: a qualitative study

scientific article

What Does Society Value About Cancer Medicines? A Discrete Choice Experiment in the Belgian Population

scientific article published on 01 December 2019